Orthopaedic metals and their potential toxicity in the arthroplasty patient. A review of current knowledge and future strategies

Journal of Bone and Joint Surgery - Series B

Volumn 89, Issue 5, 2007, Pages 567-573

  Keegan, Gemma M ^a   Learmonth, I D ^a   Case, C P ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOY; ALUMINUM; BIOLOGICAL MARKER; CALCIUM PHOSPHATE; CHROMIUM; COBALT; IRON; METAL OXIDE; MOLYBDENUM; NANOPARTICLE; NICKEL; POLYETHYLENE; TITANIUM;

ALZHEIMER DISEASE; AMNESIA; AMYOTROPHIC LATERAL SCLEROSIS; ATAXIA; BIOLOGICAL MONITORING; CARDIOMYOPATHY; CONCENTRATION (PARAMETERS); DEVELOPMENTAL DISORDER; DIALYSIS ENCEPHALOPATHY; ENDOCRINE DISEASE; ENDOMETRIUM CANCER; HEARING LOSS; HEART LEFT VENTRICLE FAILURE; HEMATOLOGIC MALIGNANCY; HIP ARTHROPLASTY; HUMAN; HYPERSENSITIVITY; IMMUNOTOXICITY; LIPID PEROXIDATION; LIVER NECROSIS; LYMPHOCYTIC INFILTRATION; MALE INFERTILITY; MELANOMA; METAL IMPLANTATION; MUSCULOSKELETAL DISEASE; NEPHROTOXICITY; NONHUMAN; ORTHOPEDIC EQUIPMENT; OXIDATIVE STRESS; PARKINSON DISEASE; PARTICLE SIZE; PARTICULATE MATTER; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTHESIS LOOSENING; RETINA DEGENERATION; REVIEW; RISK ASSESSMENT; SENILE PLAQUE; SKIN DISEASE; SYNOVIAL FLUID; TOXICOKINETICS;

ARTHROPLASTY; HUMANS; METALS; PROSTHESES AND IMPLANTS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RISK ASSESSMENT;

EID: 34250754537     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.89B5.18903     Document Type: Review

References (116)

1. The NJR 2nd Annual Report. National Joint Registry 21st Sept 2005. http://www.njrcentre.org.uk/documents/reports/2nd_annual_report.html (date last accessed 3 October 2006).
2. No authors listed. Annual Report 2002. The Swedish National Hip Arthroplasty Register April 2003. http://www.jru.orthop.gu.se/ (date last accessed 2 October 2006).
3. No authors listed. Annual Report 2004. The Swedish National Hip Arthroplasty Register May 2005. http://www.jru.orthop.gu.se/ (date last accessed 3 October 2006).
4. No authors listed. Table 12. Number and distribution of total hip replacement hospitalizations by age group and sex, Canada, Fiscal 2002 compared to Fiscal 1994. Hospital Morbidity Database, Canadian Institute for Health Information 2005. http://secure.cihi.ca/cihiweb/en/ AR30_2005_tab12_e.html (date last accessed 28 September 2006).
5. No authors listed. Biological effects of metal wear debris generated from hip implants: genotoxicity. Medicines and Healthcare Regulatory Agency 21 July 2006. http://www.mhra.gov.uk/home/ idcplg?ldcService=SS_GET_PAGE&useSecondary=true&ssDocName= CON2024535 (date last accessed 21 September 2006).
6. Wright T, Goodman S. Implant wear in total joint replacement: clinical and biologic issues, material and design considerations. Rosemount: American Academy of Orthopaedic Surgeons, 2001:176-85.
7. Jacobs JJ, Gilbert JL, Urban RM. Corrosion of metal orthopaedic implants. J Bone Joint Surg [Am] 1998;80-A:268-82.
8. Doorn PF, Campbell PA, Worrall J, et al. Metal wear particle characterization from metal on metal total hip replacements: transmission electron microscopy study of periprosthetic tissues and isolated particles. J Biomed Mater Res 1998;42:103-11.
9. Elfick APD, Green SM, Krikler S, Unsworth A. The nature and dissemination of UHMWPE wear debris retrieved from periprosthetic tissue of THR. J Biomed Mater Res 2003;65:95-108.
10. Kocijan A, Milosev I, Pihlar B. Cobalt-based alloys for orthopaedic applications studied by electrochemical and XPS analysis. J Mater Sci Mater Med 2004;15:643-50.
11. Milosev I, Metikos-Hukovic M, Strehblow HH. Passive film on orthopaedic TiA1V alloy formed in physiological solution investigated by x-ray photoelectron spectroscopy. Biomaterials 2002;21:2103-13.
12. Lorang G, DaCunha Belo M, Simers AMP, Ferreira MGS. Chemical composition of passive films on AISI-304 stainless steel. J Electrochem Soc 1994;141:3347-56.
13. Okazaki Y, Gotoh E. Comparison of metal release from various metallic biomaterials in vitro. Biomaterials 2005;26:11-21.
14. Haynes DR, Crotti JN, Haywood MR. Corrosion of and changes in biological effects of cobalt chrome alloy and 316L stainless steel prosthetic particles with age. J Biomed Mater Res 2000:49:167-75.
15. Hodgson AWE, Kurz S, Virtanen S, et al. Passive and transpassive behaviour of CoCrMo in simulated biological solutions. Electrochim Acta 2004;49:2167-78.
16. Shettlemore MG, Bundy KJ. Examination of in vivo influences on bioluminescent microbial assessment of corrosion product toxicity. Biomaterials 2001;22:2215-28.
17. Merritt K, Brown SA. Release of hexavalent chromium from corrosion of stainless steel and cobalt-chromium alloys. J Biomed Mater Res 1995;29:627-33.
18. Lewis AC, Heard PJ. The effects of calcium phosphate deposition upon corrosion of CoCr alloys and the potential for implant failure. J Biomed Mater Res 2005;75:365-73.
19. Lewis A, Kilburn MR, Heard PJ, et al. The entrapment of corrosion products from CoCr implant alloys in the deposits of calcium phosphate: a comparison of serum, synovial fluid, albumin, EDTA, and water. J Orthop Res 2006;24:1587-96.
20. Brien WW, Salvati EA, Betts F, et al. Metal levels in cemented total hip arthroplasty: a comparison of well-fixed and loose implants. Clin Orthop 1992;276:66-74.
21. Case CP, Langkamer VG, James C, et al. Widespread dissemination of metal debris from implants. J Bone Joint Surg [Br] 1994;76-B:701-12.
22. Urban RM, Jacobs JJ, Tomlinson MJ, et al. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J Bone Joint Surg [Am] 2000;82-A:457-77.
23. Olmedo DG, Tasat D, Gugliemotti MB, Cabrini RL. Titanium transport through the blood stream: an experimental study on rats. J Mater Sci Mater Med 2003;14:1099-103.
24. Engh CA Jr, Moore KID, Vinh TN, Engh GA. Titanium prosthetic wear debris in remote bone marrow: a report of two cases. J Bone Joint Surg [Am] 1997;79-A:1721-5.
25. Gambelungh A, Piccinini R, Ambrogi M, et al. Primary DNA damage in chromeplating workers. Toxicol 2003;188:187-95.
26. Lhotka C, Szekeres T, Steffan I, Zhuber K, Zweymüller K. Four-year study of cobalt and chromium blood levels in patients managed with two different metal-on-metal total hip replacements. J Orthop Res 2003;21:189-95.
27. No authors listed. Table I: List of approved workplace exposure limits. www.hse.gov.uk/coshh/table1.pdf (date last accessed 2 October 2006).
28. Morgan MS, Schaller KH. An analysis of criteria for biological limit values developed in Germany and in the United States. Int Arch Occup Environ Health 1999;72:195-204.
29. Schaffer AW, Pilger A, Engelhardt C, Zweymüller K, Ruediger HW. Increased blood cobalt and chromium after total hip replacement. Clin Toxicol 1999;37:839-44.
30. Pilger A, Schaffer A, Ruediger HW, Osterode W. Urinary 8-hydroxydeoxyguanosine and sister chromatid exchanges in patients with total hip replacements. J Toxicol Environ Health 2002;65:655-64.
31. Shukla R, Bansal V, Chaudhary M, et al. Biocompatability of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005;21:10644-54.
32. Trindade MC, Lind M, Sun D, et al. In vitro reaction to orthopaedic biomaterials by macrophages and lymphocytes isolated from patients undergoing revision surgery. Biomaterials 2001;22:253-9.
33. Podleska L, Weuster M, Dose E, et al. The impact of nanocolloidal wear-particles on human mononuclear cells. Mat-Wiss u Werkstofftechnik 2006;37:563-9 (in German).
34. Daley B, Doherty AT, Fairman B, Case CP. Wear debris from hip knee replacements causes chromosomal damage in human cells in tissue culture. J Bone Joint Surg [Br] 2004;86-B:598-606.
35. Soloviev A, Schwarz EM, Darowish M, O'Keefe RJ. Sphongomyelinase mediates macrophage activation by titanium particles independent of phagocytosis: a role for free radicals, NFkappaB and TNF-alpha. J Orthop Res 2005;23:1258-65.
36. Lohmann CH, Schwartz Z, Koster G, et al. Phagocytosis of wear debris by osteoblasts affects differentiations and local factor production in a manner dependent on particle composition. Biomaterials 2000;21:551-61.
37. Messer RL, Lucas LC. Localization of metallic ions within gingival fibroblast subcellular fractions. J Biomed Mater Res 2002;59:466-72.
38. Harris HH, Levina A, Dillon CT, et al. Time-dependent uptake, distribution and biotransformation of chromium(VI) in individual and bulk human lung cells: applications of synchrotron radiation techniques. J Biol Inorg Chem 2005;10:105-18.
39. Chen H, Davidson T, Singleton S, Garrick MD, Costa M. Nickel decreases cellular iron level and converts cytosolic aconitase to iron-regulatory protein 1 in A549 cells. Toxicol Appl Pharmacol 2005;206:275-87.
40. Forbes JR, Gros P. Iron, manganese, and cobalt transport by Nramp 1 (S1c11a1) and Nramp2 (S1c11a2) expressed at the plasma membrane. Blood 2003;102:1884-92.
41. Clodfelder BJ, Vincent JB. The time-dependent transport of chromium in adult rats from the bloodstream to the urine. J Biol Inorg Chem 2005;10:383-93.
42. Perez G, Garbossa G, DiRisio C, Vittori D, Nesse A. Disturbance of cellular iron uptake and utilisation by aluminium. J Inorg Biochem 2001;87:21-7.
43. Be Cremer K, Van Hulle M, Chery C, et al. Fractionation of vanadium complexes in serum, packed cells and tissues of Wistar rats by means of gel filtration and anion-exchange chromatography. J Biol Inorg Chem 2002;7:884-90.
44. Hallab NJ, Anderson S, Caicedo M, et al. Effects of soluble metals on human peri-implant cells. J Biomed Mater Res A 2005; 74-A:124-40.
45. Huk O, Catelas I, Mwale F, et al. Induction of apoptosis and necrosis by metal ions in vitro. J Arthroplasty 2004;19(8 Suppl 3):84-7.
46. Hanawa T, Kaga M, Itoh Y, et al. Cytotoxicities of oxides, phosphates and sulphides of metals. Biomaterials 1992;13:20-4.
47. Zhitkovich A, Shrager S, Messer J. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr-DNA adducts in the absence of oxidative DNA damage. Chem Res Toxicol 2000;13:1114-24.
48. Xu J, Bubley GJ, Detrick B, Blankenship L, Patierno SR. Chromium (VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle. Carcinogenesis 1996;17:1511-17.
49. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006:160:1-40.
50. Lloyd DR, Phillips PH, Carmichael PL. Generation of putative intrastrand crosslinks and strand breaks in DNA by transition metal ion-mediated oxygen radical attack. Chem Res Toxicol 1997;10:393-400.
51. Petit A, Mwale F, Tkaczyk C, et al. Induction of protein oxidation by cobalt and chromium ions in human U937 macrophages. Biomaterials 2005;26:4416-22.
52. Pourahmad J, O'Brien PJ, Jokor F, Daraei B. Carcinogenic metal induces sites of reactive oxygen species formation in hepatocytes. Toxicol in Vitro 2003;17:803-10.
53. Witkiewicz-Kucharczyk A, Bal W. Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis. Toxicol Lett 2006;162:29-42.
54. Chen F, Shi X. Intracellular signal transduction of cells in response to carcinogenic metals. Crit Rev Oncol Hematol 2002;42:105-21.
55. Willert HG, Buchhorn GH, Fayyazi A, et al. Metal-on-metal bearings and hyper-sensitivity in patients with artificial hip joints: a clinical and histomorphological study. J Bone Joint Surg [Am] 2005;87-A:28-36.
56. Milosev I, Trebse R, Kovac S, et al. Survivorship and retrieval analysis of Sikomet metal-on-metal total hip replacements at a mean of seven years. J Bone Joint Surg [Am] 2006;88-A:1173-82.
57. Davies AP, Willert HG, Campbell PA, Learmonth ID, Case CP. An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-on-metal joint replacements. J Bone Joint Surg [Am] 2005:87-A:18-27.
58. Hallab N, Mikecz K, Vermes C, Skipor J, Jacobs JJ. Orthopaedic implant related metal toxicity in terms of human lymphocyte reactivity to metal-protein complexes produced from cobalt-base an titanium base implant alloy degradation. Mol Cell Biochem 2001;222:127-36.
59. Vittori D, Nesse A, Perez G, Garbossa G. Morphologic and functional alterations of erythroid cells induced by long-term ingestion of aluminium. J Inorg Biochem 1999;76:113-20.
60. Ani M, Moshtaghie A. The effect of chromium on parameters related to iron-metabolism. Biol Trace Elem Res 1992;32:57-64.
61. Nayak P. Aluminium: impacts and disease. Environ Res 2002;89:101-15.
62. Tkeshelkashvili L, Tsakadze K, Khulusauri O. Effect of some nickel compounds on red blood cell characteristics. Biol Trace Elem Res 1989;21:337-42.
63. Hart A, Hester T, Sinclair K, et al. The association between metal ions from his resurfacing and reduced T-cell counts. J Bone Joint Surg [Br] 2006;88-B:449-54.
64. Savarino L, Granchi D, Ciapetti G. Effects of metal ions on white blood cells of patients with failed total joint arthroplasties. J Biomed Mater Res 1999;47:543-50.
65. Ferreira M, de Lourdes Pereira M, Garcia e Costa F, Sousa JP, de Carvalho GS. Comparative study of metallic biomaterials toxicity: a histochemical and immunohistochemical demonstration in mouse spleen. J Trace Elem Med Biol 2003;17:45-9.
66. Kurosaki K, Nakamura T, Mukai T, Endo T. Unusual findings in a fatal case of poisoning with chromate compounds. Forensic Sci Int l995;75:57-65.
67. Kametani K, Nagata T. Quantitative elemental analysis on aluminium accumulation by HVTEM-FDX in liver tissues of mice orally administered with aluminium chloride. Med Mol Morphol 2006:39:97-105.
68. Oliveira H, Santos TM, Ramalho-Santos J, de Lourdes Pereira M. Histopathological effects of hexavalent chromium in mouse kidney. Bull Environ Contam Toxicol 2006;76:977-83.
69. Barceloux DG. Chromium. Clin Toxicol 1999;37:173-94.
70. Bonde J, Vittinghus E. Urinary excretion of proteins among metal welders, Human Exp Toxicol 1996;15:1-4.
71. Nemery B. Metal toxicity and the respiratory tract. Eur Respir J 1990;3:202-19.
72. Antonini J, Lewis AB, Roberts JR, Whaley DA. Pulmonary effects of welding fumes: review of worker and experimental animal studies. Am J Indust Med 2003;43:350-60
73. Yokel R. The toxicology of aluminium in the brain: a review. Neurotoxicology 2000;21:813-28.
74. Olivieri G, Novakovic M, Savaskan E, et al. The effects of beta-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and betaamyloid secretion. Neuroscience 2002;113:849-55.
75. Youdim MB, Ben-Shachar D, Riederer P. Iron in brain functions and dysfunction with emphasis on Parkinson's disease. Eur Neurol 1991;31(Suppl 1):34-40
76. Travacio M, Polo JM, Llesuy S. Chromium (VI) induces oxidative stress inthe mouse brain. Toxicology 2001;162:139-48.
77. Garcia GB, Biancardi M, Quiroga A. Vanadium (V)-induced neurotoxicity in the rat central nervous system: a histo-immunohistochemical study. Drug Chem Toxicol 2005;28:329-44.
78. Barth A, Schaffer AW, Komaris C, et al. Neurobehavioural effects of vanadium. J Toxicol Environ Health [Am] 2002;65:677-83.
79. Barceloux D. Cobalt. J Toxicol Clin Toxicol 1999;37:201-16.
80. Linna A, Oksa P, Groundstroem K, et al. Exposure to cobalt in the production of cobalt and cobalt compounds and its effects on the heart. Occup Environ Med 2004;61:877-85.
81. Lippmann M, Ito K, Hwang JS, Maciejczyk P, Chen LC. Cardiovascular effects of nickel in ambient air. Environ Health Perspect 2006;114:1662-9.
82. Jeffery E, Ebero K, Burgess E, Cannata J, Greger JL Systemic aluminum toxicity: effects on bone, hematopoietic tissue, and kidney. J Toxicol Environ Health 1996;48:649-65
83. Vermes C, Glant TT, Hallab NJ, et al. The potential role of the osteoblast in the development of periprosthetic osteolysis: review of in vitro osteoblast responses to wear debris, corrosion products, and cytokines and growth factors. J Arthroplasty 2001;16(Suppl 1):95-100.
84. Darbre PD. Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast. J Appl Toxicol 2006;26:191-7.
85. Murthy RC, Junaid M, Saxena D. Ovarian dysfunction in mice following chromium (VI) exposure. Toxicol Lett 1996;89:147-54.
86. Brock T, Stopford W. Bioaccessibility of metals in human health risk assessment: evaluating risk from exposure to cobalt compounds. J Environ Monit 2003;5:171-7.
87. Prescott E, Netterstrom B, Faber J, et al. Effect of occupational exposure to cobalt blue dyes on the thyroid volume and function of female plate painters. Scand J Work Environ Health 1992;18:101-4.
88. Lu Z-Y, Gong H, Ameniya J. Aluminum chloride induces retinal changes in the rat. Toxicol Sci 2002;66:253-60.
89. Khosla PK, Murthy KS, Tewari H. Retinal toxicity of trace elements. Indian J Ophthalmol 1987;35:311-14.
90. Steens W, von Foerster G, Katzer A. Severe cobtalt poisoning with loss of sight after ceramic-metal pairing in a hip: a case report. Acta Orthop 2006;77:830-2.
91. Hallab N, Jacobs J, Black J. Hypersensitivity to metallic biomaterials: a review of leukocyte migration inhibition assays. Biomaterials 2000;21:1301-14.
92. Hallab N, Mikecz K, Jacobs J. Metal sensitivity in patients with orthopaedic implants. J Bone Joint Surg [Am] 2001;83-A:428-36.
93. Aruldhas M, Subramaniam S, Sekar P, et al. Chronic chromium exposure-induced changes in testicular histoarchitecture are associated with oxidative stress: study in a non-human primate (Macaca radiata Geoffroy). Human Reprod 2005;20:2801-13.
94. Elbetieha A, Al-Hamood MH. Long-term exposure of male and female mice to tri-valent and hexavalent chromium compounds: effect on fertility. Toxicol 1997:116:39-47.
95. Bonde J. The risk of male subfecundity attributable to welding of metals: studies of semen quality, infertility, adverse pregnancy outcome, and childhood malignancy. Int J Androl 1993:16(Suppl 1):1-29.
96. Kumar S, Sathwara NG, Gautam AK, et al. Semen quality of industrial workers occupationally exposed to chromium. J Occup Health 2005; 47:424-30,
97. Pandey R, Kumar R, Singh SP, Saxena OK, Srivastava SP. Male reproductive effect of nickel sulphate in mice. Biometals 1999; 12:339-46.
98. Domingo JL. Vanadium: a review of the reproductive and developmental toxicity. Reprod Toxicol 1996;10:175-82.
99. Llobet JM, Colamina MT, Sirvent JJ, Domingo JL, Corbella J. Reproductive toxicology of aluminium in male mice. Fundam Appl Toxicol 1995;25:45-51.
100. Anderson MB, Pedigo NG, Katz RP, George WJ. Histopathology of testes from mice chronically treated with cobalt. Reprod Toxicol 1992;6:41-50.
101. Kanojia R, Junaid M, Murthy P. Embryo and fetotoxicity of hexavalent chromium a long-term study. Toxicol Lett 1998; 95:165-72.
102. Domingo J. Metal-induced developmental toxicity in mammals: a review. J Toxicol Environ Health 1994;42:123-41.
103. Yu W, Sipowicz MA, Haines DG, et al. Preconception urethane or chromium (III) treatment of male mice: multiple neoplastic and non-neoplastic changes in offspring. Toxicol Appl Pharmacol 1999;158:161-76.
104. Morgan A, El-Tawil O. Effects of ammonium metavandate on ferfility and reproductive performance of adult male and female rats. Pharmacol Res 2003;47:75-85.
105. Hjollund N, Bonde JP Jensen JK, et al. Male-mediated spontaneous abortion among spouses of stainless steel welders. Scand J Work Environ Health 2000;26:187-92.
106. O'Leary LM, Hicks AM, Peters JM, London S. Parental occupational exposures and risk of childhood cancer: a review. Am J Int Med 1991;20:17-35.
107. Meldrum R, Feinberg JR, Capello WN, Detterline AJ. Clinical outcome and incidence of pregnancy after bipolar and total hip arthroplasty in young women. J Arthroplasty 2003;18:879-85.
108. Ladon D, Doherty A, Newson R, et al. Changes in metal levels and chromosome aberrations in the peripheral blood of patients after metal-on-metal hip arthroplasty. J Arthroplasty 2004;19(Suppl 3):78-83.
109. Iarmarcovai G, Sari-Minodier I, Chagpoul F, et al. Risk assessment of welders using analysis of eight metals by ICP-MS in blood and urine and DNA damage evaluation by the comet and micronucleus assays: influence of XRCCI and XRCC2 polymerphisms. Mutagenesis 2005;20:425-32.
110. Cole P, Rodu B. Epidemiologic studies of chrome and cancer mortality: a series of meta-analyses. Reg Toxicol Pharmacol 2005;43:225-31.
111. Visuri T, Pukkala E, Pulkinen P, Paavolainen P. Decreased cancer risk in patients who have been operated on with total hip and knee arthroplasty for primary osteoarthritis: a meta-analysis of 6 Nordic cohorts with 73,000 patients. Acta Orthop Scand 2003;74:351-60.
112. Visuri T, Pukkala E, Polkkinen P, Paavolainen P. Cancer incidence and causes of death among total hip replacement patients a review based on Nordic cohorts with a special emphasis on metal-on-metal bearings. Proc Instn Mech Engrs 2006;220:399-407.
113. No authors listed. IARC monographs on the evaluation of carcinogenic risk to humans. 2004. http://monographs.iarc.fr/ (date last accessed 5 October 2006).
114. Barlow S, Renwick AG, Kleiner J, et al. Risk assessment of substances that are both genotoxic and carcinogenic: report of an International Conference organised by EFSA and WHO with support of ILSI Europe. Food Chem Toxicol 2006:44:1636-50.
115. Rissanen P, Aro S, Slatis P, et al. Health and quality of life before and after hip or knee anthroplasty. J Arthroplasty 1995;10:169-75.
116. Jacobs J, Skipor AK, Patterson LM, et al. Metal release in patients who have had primary total hip arthroplasty: a prospective, controlled longitudinal study. J Bone Joint Surg [Am] 1998:80-A:1447-58.